Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)
- Status
- UNKNOWN
- Phase
- PHASE4
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
- Status
- RECRUITING
- Phase
- NA
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- NA
Identification of Breath Biomarkers in Esophageal Cancer
- Status
- COMPLETED
- Phase
- N/A
Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
- Status
- RECRUITING
- Phase
- PHASE2
Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2